BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 38727692)

  • 1. Light Scattering by Vitreous of Humans With Vision Degrading Myodesopsia From Floaters.
    Paniagua-Diaz AM; Nguyen JH; Artal P; Gui W; Sebag J
    Invest Ophthalmol Vis Sci; 2024 May; 65(5):20. PubMed ID: 38727692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of Vitreous Structure and Visual Function after Neodymium:Yttrium-Aluminum-Garnet Laser Vitreolysis.
    Nguyen JH; Nguyen-Cuu J; Yu F; Yee KM; Mamou J; Silverman RH; Ketterling J; Sebag J
    Ophthalmology; 2019 Nov; 126(11):1517-1526. PubMed ID: 31471088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vitreous Structure and Visual Function in Myopic Vitreopathy Causing Vision-Degrading Myodesopsia.
    Nguyen JH; Nguyen-Cuu J; Mamou J; Routledge B; Yee KMP; Sebag J
    Am J Ophthalmol; 2021 Apr; 224():246-253. PubMed ID: 32950508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ultrasound-based quantification of vitreous floaters correlates with contrast sensitivity and quality of life.
    Mamou J; Wa CA; Yee KM; Silverman RH; Ketterling JA; Sadun AA; Sebag J
    Invest Ophthalmol Vis Sci; 2015 Jan; 56(3):1611-7. PubMed ID: 25613948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RECURRENT FLOATERS AFTER LIMITED VITRECTOMY FOR VISION DEGRADING MYODESOPSIA.
    Boneva SK; Nguyen JH; Gui W; Hoerig C; Mamou J; Ketterling JA; Chong LP; Sebag J
    Retina; 2023 Jul; 43(7):1114-1121. PubMed ID: 36940362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of vitreous opacities on straylight measurements.
    Castilla-Marti M; van den Berg TJ; de Smet MD
    Retina; 2015 Jun; 35(6):1240-6. PubMed ID: 25650709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vitreous and Vision Degrading Myodesopsia.
    Sebag J
    Prog Retin Eye Res; 2020 Nov; 79():100847. PubMed ID: 32151758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitrectomy Improves Contrast Sensitivity in Multifocal Pseudophakia With Vision Degrading Myodesopsia.
    Nguyen JH; Yee KMP; Nguyen-Cuu J; Mamou J; Sebag J
    Am J Ophthalmol; 2022 Dec; 244():196-204. PubMed ID: 35562070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-Effectiveness of Limited Vitrectomy for Vision-Degrading Myodesopsia.
    Rostami B; Nguyen-Cuu J; Brown G; Brown M; Sadun AA; Sebag J
    Am J Ophthalmol; 2019 Aug; 204():1-6. PubMed ID: 30849342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vision degrading myodesopsia assessed with optos ultra-widefield scanning laser ophthalmoscope.
    Lin T; Shi C; Wu B; Pazo EE; Shen L
    BMC Ophthalmol; 2023 Oct; 23(1):425. PubMed ID: 37864149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of aging vitreous on contrast sensitivity function.
    Garcia GA; Khoshnevis M; Yee KMP; Nguyen JH; Nguyen-Cuu J; Sadun AA; Sebag J
    Graefes Arch Clin Exp Ophthalmol; 2018 May; 256(5):919-925. PubMed ID: 29536170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-Term Safety and Efficacy of Limited Vitrectomy for Vision Degrading Vitreopathy Resulting from Vitreous Floaters.
    Sebag J; Yee KMP; Nguyen JH; Nguyen-Cuu J
    Ophthalmol Retina; 2018 Sep; 2(9):881-887. PubMed ID: 31047219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vitrectomy for floaters: prospective efficacy analyses and retrospective safety profile.
    Sebag J; Yee KM; Wa CA; Huang LC; Sadun AA
    Retina; 2014 Jun; 34(6):1062-8. PubMed ID: 24296397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The (lack of) relation between straylight and visual acuity. Two domains of the point-spread-function.
    van den Berg TJTP
    Ophthalmic Physiol Opt; 2017 May; 37(3):333-341. PubMed ID: 28271538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quality of vision in patients with fuchs endothelial dystrophy and after descemet stripping endothelial keratoplasty.
    van der Meulen IJ; Patel SV; Lapid-Gortzak R; Nieuwendaal CP; McLaren JW; van den Berg TJ
    Arch Ophthalmol; 2011 Dec; 129(12):1537-42. PubMed ID: 21825178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of vitrectomy for epiretinal membrane on visual function and vision-related quality of life.
    Okamoto F; Okamoto Y; Hiraoka T; Oshika T
    Am J Ophthalmol; 2009 May; 147(5):869-74, 874.e1. PubMed ID: 19200531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. YAG Laser Vitreolysis vs Sham YAG Vitreolysis for Symptomatic Vitreous Floaters: A Randomized Clinical Trial.
    Shah CP; Heier JS
    JAMA Ophthalmol; 2017 Sep; 135(9):918-923. PubMed ID: 28727887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surgery for floaters.
    Mura M; Engelbrecht LA; de Smet MD; Papadaki TG; van den Berg TJ; Tan HS
    Ophthalmology; 2011 Sep; 118(9):1894-1894.e1. PubMed ID: 21889665
    [No Abstract]   [Full Text] [Related]  

  • 19. Nd:YAG laser vitreolysis versus pars plana vitrectomy for vitreous floaters.
    Kokavec J; Wu Z; Sherwin JC; Ang AJ; Ang GS
    Cochrane Database Syst Rev; 2017 Jun; 6(6):CD011676. PubMed ID: 28570745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New Terminology and Methodology for the Assessment of the Vitreous, Its Floaters and Opacities, and Their Effect on Vision: Standardized and Kinetic Anatomical and Functional Testing of Vitreous Floaters and Opacities (SK VFO Test).
    Stanga PE; Valentin Bravo FJ; Reinstein UI; Stanga SFE; Marshall J; Archer TJ; Reinstein DZ
    Ophthalmic Surg Lasers Imaging Retina; 2023 May; 54(5):306-315. PubMed ID: 37184989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.